1-3 of 3 results for subject:Finance
Librarians' tools
- Search time
- 0.148 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Finance
- We searched for
- subject_t:Finance OR subject_ses:91257
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, with reference to section 3.7.1 of the NHS Operational Planning Guidance 2019-20, how much funding is being held back from overall CCG allocations to create a time-limited national budget for flash glucose monitoring devices; how much funding is being...
To ask the Secretary of State for Health and Social Care, with reference to section 3.7.1 of the NHS Operational Planning Guidance 2019-20, how much funding is being held back from overall CCG allocations to create a time-limited national budget for flash glucose monitoring devices; how much funding is being...
In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to availability of this device. NHS England is currently working up detailed clinical criteria for who would be able to access the device. NHS England estimates that current guidelines on the use of flash glucose monitoring suggest that it could be beneficial for around 20% of those with type 1 diabetes (20% or approximately 45,000 people).
NHS England is committed to making funding available in 2019/20 and 2020/21 which will be used to reimburse clinical commissioning groups based on the number of prescriptions made for flash glucose monitor sensors. Details of the funding arrangements have not yet been confirmed.
To ask the Secretary of State for Health and Social Care, with reference to section of 3.7.1 of the NHS Operational Planning Guidance 2019-20, what estimate his Department has made of the number of people with type 1 diabetes that will be provided with flash glucose monitoring devices as a...
To ask the Secretary of State for Health and Social Care, with reference to section of 3.7.1 of the NHS Operational Planning Guidance 2019-20, what estimate his Department has made of the number of people with type 1 diabetes that will be provided with flash glucose monitoring devices as a...
In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to availability of this device. NHS England is currently working up detailed clinical criteria for who would be able to access the device. NHS England estimates that current guidelines on the use of flash glucose monitoring suggest that it could be beneficial for around 20% of those with type 1 diabetes (20% or approximately 45,000 people).
NHS England is committed to making funding available in 2019/20 and 2020/21 which will be used to reimburse clinical commissioning groups based on the number of prescriptions made for flash glucose monitor sensors. Details of the funding arrangements have not yet been confirmed.
To ask the Secretary of State for Health and Social Care, with reference to section 3.7.1 of the NHS Operational Planning Guidance 2019-20 which NHS organisations will have control of the time-limited national budget for flash glucose monitoring devices.
To ask the Secretary of State for Health and Social Care, with reference to section 3.7.1 of the NHS Operational Planning Guidance 2019-20 which NHS organisations will have control of the time-limited national budget for flash glucose monitoring devices.
In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to availability of this device. NHS England is currently working up detailed clinical criteria for who would be able to access the device. NHS England estimates that current guidelines on the use of flash glucose monitoring suggest that it could be beneficial for around 20% of those with type 1 diabetes (20% or approximately 45,000 people).
NHS England is committed to making funding available in 2019/20 and 2020/21 which will be used to reimburse clinical commissioning groups based on the number of prescriptions made for flash glucose monitor sensors. Details of the funding arrangements have not yet been confirmed.